High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction

Gene Therapy

Volumn 6, Issue 11, 1999, Pages 1876-1883

  Yu, Hong ^a,c   Eton, D ^a   Wang, Y ^a   Kumar, S R ^a   Tang, L ^a   Terramani, T T ^a   Benedict, C ^a   Hung, G ^b   Anderson, W F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HOUSE EAR INSTITUTE   (United States)

^c Dept of Surgery/Vascular Division ^*  (United States)

Author keywords

Endothelial cells; Gene transfer; Plasminogen activator; Pseudotransduction; Retroviral vector; Smooth muscle cells

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TISSUE PLASMINOGEN ACTIVATOR; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VASCULAR TISSUE; VESICULAR STOMATITIS VIRUS;

CELL DIVISION; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LEUKEMIA VIRUS, MURINE; MUSCLE, SMOOTH, VASCULAR; SAPHENOUS VEIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0032750447     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301019     Document Type: Article

References (34)

1. Wilson JM et al. Implantation of vascular grafts lined with genetically modified endothelial cells. Science 1989; 244: 1344-1346.
2. Nabel EG et al. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 1989; 244: 1342-1344.
3. Dichek DA, Lee SW, Nguyen NH. Characterization of recombinant plasminogen activator production by primate endothelial cells transduced with retroviral vectors. Blood 1994; 84: 504-516.
4. Geary RL et al. Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy. Hum Gene Ther 1994; 5: 1211-1216.
5. Ekhterae D, Stanley JC. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells. J Vasc Surg 1995; 21: 953-962.
6. Rade JJ, Schulick AH, Virmani R, Dichek DA. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nature Med 1996; 2: 293-8.
7. Laitinen M et al. Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. Hum Gene Ther 1997; 8: 1645-1650.
8. Rekhter MD et al. Gene transfer into normal and atherosclerotic human blood vessels (see comments). Circ Res 1998; 82: 1243-1252.
9. Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Meth Enzymol 1993; 217: 581-599.
10. Inaba M et al. Retroviral gene transfer: effects on endothelial cell phenotype. J Surg Res 1998; 78: 31-36.
11. Zelenock JA et al. Improved retroviral transduction efficiency of vascular cells in vitro and in vivo during clinically relevant incubation periods using centrifugation to increase viral titers. J Vasc Surg 1997; 26: 119-127.
12. Friedmann T, Yee JK. Pseudotyped retroviral vectors for studies of human gene therapy. Nature Med 1995; 1: 275-277.
13. Schnell MJ et al. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci USA 1996; 93: 11359-11365.
14. Burns JC et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells (see comments). Proc Natl Acad Sci USA 1993; 90: 8033-8037.
15. Chen ST et al. Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system. Proc Natl Acad Sci USA 1996; 93: 10057-10062.
16. Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA 1996; 93: 11400-11406.
17. Arai T et al. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines. J Virol 1998; 72: 1115-1121.
18. Liu ML, Winther BL, Kay MA. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Virol 1996; 70: 2497-2502.
19. Gallardo HF, Tan C, Ory D, Sadelain M. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glyco-protein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 1997; 90: 952-957.
20. An DS et al. High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells. J Virol 1997; 71: 1397-1404.
21. Sharma S, Cantwell M, Kipps TJ, Friedmann T. Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector, Proc Natl Acad Sci USA 1996; 93: 11842-11847.
22. Miller DC, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection (published erratum appears in Mol Cell Biol 1992 Jan;12(1):433). Mol Cell Biol 1990; 10: 4239-4242.
23. - hematopoietic progenitor cells. Gene Therapy 1997; 4: 918-927.
24. Schlegel R, Tralka TS, Willingham MC, Pastan I. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 1983; 32: 639-646.
25. Conti C, Mastromarino P, Ciuffarella MG, Orsi N. Characterization of rat brain cellular membrane components acting as receptors for vesicular stomatitis virus. Brief report. Arch Virol 1988; 99: 261-269.
26. Kavanaugh MP et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 1994; 91: 7071-7075.
27. DuBridge RB et al. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987; 7: 379-387.
28. Eton D et al. Genetic engineering of stent-grafts with a highly efficient pseudotyped rctroviral vector. J Vasc Surg 1999; 29: 863-873.
29. Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984; 99: 2034-2040.
30. Han JY et al. Identification of envelope protein residues required for the expended host range of 10A1 murine leukemia virus. J Virol 1997; 71: 8103-8108.
31. Soneoka Y et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628-633.
32. MacKrell AJ, Soong NW, Curtis CM, Anderson WF. Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J Virol 1996; 70: 1768-1774.
33. Yee JK, Friedmann T, Burns JC. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Meth Cell Biol 1994; 43 Pt A: 99-112.
34. Morgan RA et al. Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins. J Virol 1993; 67: 4712-4721.